Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20071775 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Conditions: Lung Cancer;   Breast Cancer;   Prostate Cancer;   Tumors (Others);   Ovarian Cancer
Intervention: Biological: MVA-brachyury- TRICOM

Study has passed its completion date and status has not been verified in more than two years.